Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting
- PMID: 18477651
- DOI: 10.1093/aje/kwn099
Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting
Abstract
The concept of covariate adjustment is well established in therapeutic and etiologic studies. However, it has received little attention in the growing area of medical research devoted to the development of markers for disease diagnosis, screening, or prognosis, where classification accuracy, rather than association, is of primary interest. In this paper, the authors demonstrate the need for covariate adjustment in studies of classification accuracy, discuss methods for adjusting for covariates, and distinguish covariate adjustment from several other related, but fundamentally different, uses for covariates. They draw analogies and contrasts throughout with studies of association.
Similar articles
-
Bayesian semiparametric estimation of covariate-dependent ROC curves.Biostatistics. 2014 Apr;15(2):353-69. doi: 10.1093/biostatistics/kxt044. Epub 2013 Oct 29. Biostatistics. 2014. PMID: 24174579 Free PMC article.
-
Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.DNA Cell Biol. 2015 Mar;34(3):189-200. doi: 10.1089/dna.2014.2663. Epub 2014 Dec 18. DNA Cell Biol. 2015. PMID: 25521481 Free PMC article.
-
[Screening and prevention of prostate cancer].MMW Fortschr Med. 2010 May 13;152(19):37-9. doi: 10.1007/BF03366554. MMW Fortschr Med. 2010. PMID: 20557000 German. No abstract available.
-
Prostate-specific antigen as a tumor marker in prostate cancer.Int J Urol. 1994 Jun;1(2):99-113. doi: 10.1111/j.1442-2042.1994.tb00018.x. Int J Urol. 1994. PMID: 7543013 Review. No abstract available.
-
PSA screening for prostate cancer: the current controversy.Ann Oncol. 1998 Dec;9(12):1293-6. doi: 10.1023/a:1008428327309. Ann Oncol. 1998. PMID: 9932158 Review. No abstract available.
Cited by
-
Diagnostic evaluation of pharmacokinetic features of functional markers.J Biopharm Stat. 2023 May 4;33(3):307-323. doi: 10.1080/10543406.2022.2148163. Epub 2022 Nov 25. J Biopharm Stat. 2023. PMID: 36426623 Free PMC article.
-
Methodological issues of confounding in analytical epidemiologic studies.Caspian J Intern Med. 2012 Summer;3(3):488-95. Caspian J Intern Med. 2012. PMID: 24009920 Free PMC article. Review.
-
Measurement of cooling detection thresholds for identification of diabetic sensorimotor polyneuropathy in type 1 diabetes.PLoS One. 2014 Sep 12;9(9):e106995. doi: 10.1371/journal.pone.0106995. eCollection 2014. PLoS One. 2014. PMID: 25216179 Free PMC article.
-
Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility.Front Surg. 2024 Mar 13;11:1363431. doi: 10.3389/fsurg.2024.1363431. eCollection 2024. Front Surg. 2024. PMID: 38544490 Free PMC article.
-
Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer.Prostate Cancer Prostatic Dis. 2025 Mar;28(1):45-55. doi: 10.1038/s41391-024-00840-0. Epub 2024 Jun 10. Prostate Cancer Prostatic Dis. 2025. PMID: 38858447 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources